Comparative proteome profile during the early period of small-for-size liver transplantation in rats revealed the protective role of Prdx5

Journal of Hepatology

Volumn 53, Issue 1, 2010, Pages 73-83

  Wu, Jindao ^a,b   Tang, Qiyun ^a   Shen, Jian ^a   Yao, Aihua ^a   Wang, Fuqiang ^b   Pu, Liyong ^a   Yu, Yue ^a   Li, Xiangcheng ^a   Li, Guoqiang ^a   Zhang, Feng ^a   Sun, Beicheng ^a   Kong, Lianbao ^a   Li, Donghua ^a   Zhang, Yewei ^b   Guo, Xuejiang ^b   Wang, Xuehao ^a  

^a BEIJING HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Comparative proteome; Oxidative stress; Regeneration; Small for size liver transplantation

Indexed keywords

ADENOVIRUS VECTOR; PEROXIREDOXIN 5; PEROXIREDOXIN; PROTEOME; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SHAM PROCEDURE; SMALL FOR SIZE GRAFT SYNDROME; SMALL FOR SIZE LIVER TRANSPLANTATION; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; ANIMAL; APOPTOSIS; GENE EXPRESSION; GENE THERAPY; GENETICS; HUMAN; LIVER; LIVING DONOR; MASS SPECTROMETRY; METABOLISM; ORGAN SIZE; OXIDATIVE STRESS; SYNDROME; TIME; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; APOPTOSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION; GENE THERAPY; HUMANS; LIVER; LIVER TRANSPLANTATION; LIVING DONORS; MODELS, ANIMAL; ORGAN SIZE; OXIDATIVE STRESS; PEROXIREDOXINS; PROTEOME; RATS; RECOMBINANT PROTEINS; REPERFUSION INJURY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SYNDROME; TIME FACTORS; GENETIC THERAPY;

EID: 77953233339     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.01.032     Document Type: Article

References (72)

1. Nishizaki T., Ikegami T., Hiroshige S., Hashimoto K., Uchiyama H., Yoshizumi T., et al. Small graft for living donor liver transplantation. Ann Surg 233 (2001) 575-580
2. Dahm F., Georgiev P., and Clavien P.A. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant 5 (2005) 2605-2610
3. Troisi R., Ricciardi S., Smeets P., Petrovic M., Van Maele G., Colle I., et al. Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transplant 5 (2005) 1397-1404
4. Demetris A.J., Kelly D.M., Eghtesad B., Fontes P., Wallis Marsh J., Tom K., et al. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol 30 (2006) 986-993
5. Ben-Haim M., Emre S., Fishbein T.M., Sheiner P.A., Bodian C.A., Kim-Schluger L., et al. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl 7 (2001) 948-953
6. Guo L., Haga S., Enosawa S., Naruse K., Harihara Y., Sugawara Y., et al. Improved hepatic regeneration with reduced injury by redox factor-1 in a rat small-sized liver transplant model. Am J Transplant 4 (2004) 879-887
7. Man K., Fan S.T., Lo C.M., Liu C.L., Fung P.C., Liang T.B., et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 237 (2003) 256-264
8. Man K., Lo C.M., Lee T.K., Li X.L., Ng I.O., and Fan S.T. Intragraft gene expression profiles by cDNA microarray in small-for-size liver grafts. Liver Transpl 9 (2003) 425-432
9. Man K., Lo C.M., Ng I.O., Wong Y.C., Qin L.F., Fan S.T., et al. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg 136 (2001) 280-285
10. Fan C., Zwacka R.M., and Engelhardt J.F. Therapeutic approaches for ischemia/reperfusion injury in the liver. J Mol Med 77 (1999) 577-592
11. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312 (1985) 159-163
12. Colletti L.M., Kunkel S.L., Walz A., Burdick M.D., Kunkel R.G., Wilke C.A., et al. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 23 (1996) 506-514
13. Shirasugi N., Wakabayashi G., Shimazu M., Oshima A., Shito M., Kawachi S., et al. Up-regulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia/reperfusion injury. Transplantation 64 (1997) 1398-1403
14. Kelly D.M., Demetris A.J., Fung J.J., Marcos A., Zhu Y., Subbotin V., et al. Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft. Liver Transpl 10 (2004) 253-263
15. Tang L.M., Wang Y.P., Wang K., Pu L.Y., Zhang F., Li X.C., et al. Protective effect of adenosine A2A receptor activation in small-for-size liver transplantation. Transpl Int 20 (2007) 93-101
16. He S., Atkinson C., Qiao F., Cianflone K., Chen X., and Tomlinson S. A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice. J Clin Invest 119 (2009) 2304-2316
17. Kamada N., and Calne R.Y. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 93 (1983) 64-69
18. Zhu Y.F., Cui Y.G., Guo X.J., Wang L., Bi Y., Hu Y.Q., et al. Proteomic analysis of effect of hyperthermia on spermatogenesis in adult male mice. J Proteome Res 5 (2006) 2217-2225
19. de Hoon M.J., Imoto S., Nolan J., and Miyano S. Open source clustering software. Bioinformatics 20 (2004) 1453-1454
20. Saldanha A.J. Java Treeview - extensible visualization of microarray data. Bioinformatics 20 (2004) 3246-3248
21. Armstrong D.J., Hiscott P., Batterbury M., and Kaye S. Corneal stromal cells (keratocytes) express thrombospondins 2 and 3 in wound repair phenotype. Int J Biochem Cell Biol 34 (2002) 588-593
22. Vollmar B., Menger M.D., Glasz J., Leiderer R., and Messmer K. Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury. Am J Physiol 267 (1994) G786-G793
23. Selzner M., Camargo C.A., and Clavien P.A. Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6. Hepatology 30 (1999) 469-475
24. Selzner N., Selzner M., Tian Y., Kadry Z., and Clavien P.A. Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: a TNF-alpha/IL-6-dependent mechanism. Hepatology 36 (2002) 812-818
25. Debonera F., Wang G., Xie J., Que X., Gelman A., Leclair C., et al. Severe preservation injury induces Il-6/STAT3 activation with lack of cell cycle progression after partial liver graft transplantation. Am J Transplant 4 (2004) 1964-1971
26. Fausto N. Liver regeneration. J Hepatol 32 (2000) 19-31
27. Olthoff K.M. Small size and disease severity in living donation: a difficult match. Liver Transpl 15 (2009) 457-459
28. Petersen B.E., Zajac V.F., and Michalopoulos G.K. Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology 27 (1998) 1030-1038
29. Mao L., Qiu Y.D., Fang S., Wu Y.F., Liu H., and Ding Y.T. Liver progenitor cells activated after 30% small-for-size liver transplantation in rats: a preliminary study. Transplant Proc 40 (2008) 1635-1640
30. Jung T., Catalgol B., and Grune T. The proteasomal system. Mol Aspects Med (2009)
31. Amidi F., French B.A., Chung D., Halsted C.H., Medici V., and French S.W. M-30 and 4HNE are sequestered in different aggresomes in the same hepatocytes. Exp Mol Pathol 83 (2007) 296-300
32. Terman A., and Brunk U.T. Lipofuscin. Int J Biochem Cell Biol 36 (2004) 1400-1404
33. Catley L., Weisberg E., Kiziltepe T., Tai Y.T., Hideshima T., Neri P., et al. Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells. Blood 108 (2006) 3441-3449
34. Rhee S.G., Chae H.Z., and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38 (2005) 1543-1552
35. Seo M.S., Kang S.W., Kim K., Baines I.C., Lee T.H., and Rhee S.G. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem 275 (2000) 20346-20354
36. Oberley T.D., Verwiebe E., Zhong W., Kang S.W., and Rhee S.G. Localization of the thioredoxin system in normal rat kidney. Free Radic Biol Med 30 (2001) 412-424
37. Krutilina R.I., Kropotov A.V., Leutenegger C., and Serikov V.B. Migrating leukocytes are the source of peroxiredoxin V during inflammation in the airways. J Inflamm (Lond) 3 (2006) 13
38. Kropotov A.V., Grudinkin P.S., Pleskach N.M., Gavrilov B.A., Tomilin N.V., and Zhivotovsky B. Downregulation of peroxiredoxin V stimulates formation of etoposide-induced double-strand DNA breaks. FEBS Lett 572 (2004) 75-79
39. Zhou Y., Kok K.H., Chun A.C., Wong C.M., Wu H.W., Lin M.C., et al. Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem Biophys Res Commun 268 (2000) 921-927
40. Ishitani R., Tanaka M., Sunaga K., Katsube N., and Chuang D.M. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 53 (1998) 701-707
41. Sawa A., Khan A.A., Hester L.D., and Snyder S.H. Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci USA 94 (1997) 11669-11674
42. Kiang J.G., and Tsokos G.C. Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol Ther 80 (1998) 183-201
43. 2+ disturbances, and cell death in renal epithelial cells. J Biol Chem 272 (1997) 21751-21759
44. Clary D.O., Griff I.C., and Rothman J.E. SNAPs, a family of NSF attachment proteins involved in intracellular membrane fusion in animals and yeast. Cell 61 (1990) 709-721
45. Nakajima K., Hirose H., Taniguchi M., Kurashina H., Arasaki K., Nagahama M., et al. Involvement of BNIP1 in apoptosis and endoplasmic reticulum membrane fusion. EMBO J 23 (2004) 3216-3226
46. Aouacheria A., Brunet F., and Gouy M. Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators. Mol Biol Evol 22 (2005) 2395-2416
47. Emadali A., Nguyen D.T., Rochon C., Tzimas G.N., Metrakos P.P., and Chevet E. Distinct endoplasmic reticulum stress responses are triggered during human liver transplantation. J Pathol 207 (2005) 111-118
48. Pallet N., Bouvier N., Bendjallabah A., Rabant M., Flinois J.P., Hertig A., et al. Cyclosporine-induced endoplasmic reticulum stress triggers tubular phenotypic changes and death. Am J Transplant 8 (2008) 2283-2296
49. Pallet N., Fougeray S., Beaune P., Legendre C., Thervet E., and Anglicheau D. Endoplasmic reticulum stress: an unrecognized actor in solid organ transplantation. Transplantation 88 (2009) 605-613
50. Symons M., and Settleman J. Rho family GTPases: more than simple switches. Trends Cell Biol 10 (2000) 415-419
51. Olofsson B. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell Signal 11 (1999) 545-554
52. Maddala R., Reneker L.W., Pendurthi B., and Rao P.V. Rho GDP dissociation inhibitor-mediated disruption of Rho GTPase activity impairs lens fiber cell migration, elongation and survival. Dev Biol 315 (2008) 217-231
53. Attwood P.V. The structure and the mechanism of action of pyruvate carboxylase. Int J Biochem Cell Biol 27 (1995) 231-249
54. Schiffers P.M., Henrion D., Boulanger C.M., Colucci-Guyon E., Langa-Vuves F., van Essen H., et al. Altered flow-induced arterial remodeling in vimentin-deficient mice. Arterioscler Thromb Vasc Biol 20 (2000) 611-616
55. Henrion D., Terzi F., Matrougui K., Duriez M., Boulanger C.M., Colucci-Guyon E., et al. Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin. J Clin Invest 100 (1997) 2909-2914
56. Helmke B.P., Goldman R.D., and Davies P.F. Rapid displacement of vimentin intermediate filaments in living endothelial cells exposed to flow. Circ Res 86 (2000) 745-752
57. Nieminen M., Henttinen T., Merinen M., Marttila-Ichihara F., Eriksson J.E., and Jalkanen S. Vimentin function in lymphocyte adhesion and transcellular migration. Nat Cell Biol 8 (2006) 156-162
58. Wang N., and Stamenovic D. Contribution of intermediate filaments to cell stiffness, stiffening, and growth. Am J Physiol Cell Physiol 279 (2000) C188-C194
59. Lehmann T.G., Wheeler M.D., Schwabe R.F., Connor H.D., Schoonhoven R., Bunzendahl H., et al. Gene delivery of Cu/Zn-superoxide dismutase improves graft function after transplantation of fatty livers in the rat. Hepatology 32 (2000) 1255-1264
60. Coito A.J., Buelow R., Shen X.D., Amersi F., Moore C., Volk H.D., et al. Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation 74 (2002) 96-102
61. Song J., Zhang Y.W., Yao A.H., Yu Y., Hua Z.Y., Pu L.Y., et al. Adenoviral cardiotrophin-1 transfer improves survival and early graft function after ischemia and reperfusion in rat small-for-size liver transplantation model. Transpl Int 21 (2008) 372-383
62. Kinnula V.L., Lehtonen S., Koistinen P., Kakko S., Savolainen M., Kere J., et al. Two functional variants of the superoxide dismutase genes in Finnish families with asthma. Thorax 59 (2004) 116-119
63. Wang M.X., Wei A., Yuan J., Trickett A., Knoops B., and Murrell G.A. Expression and regulation of peroxiredoxin 5 in human osteoarthritis. FEBS Lett 531 (2002) 359-362
64. Plaisant F., Clippe A., Vander Stricht D., Knoops B., and Gressens P. Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice. Free Radic Biol Med 34 (2003) 862-872
65. Wang M.X., Wei A., Yuan J., Clippe A., Bernard A., Knoops B., et al. Antioxidant enzyme peroxiredoxin 5 is upregulated in degenerative human tendon. Biochem Biophys Res Commun 284 (2001) 667-673
66. Banmeyer I., Marchand C., Verhaeghe C., Vucic B., Rees J.F., and Knoops B. Overexpression of human peroxiredoxin 5 in subcellular compartments of Chinese hamster ovary cells: effects on cytotoxicity and DNA damage caused by peroxides. Free Radic Biol Med 36 (2004) 65-77
67. Yuan J., Murrell G.A., Trickett A., Landtmeters M., Knoops B., and Wang M.X. Overexpression of antioxidant enzyme peroxiredoxin 5 protects human tendon cells against apoptosis and loss of cellular function during oxidative stress. Biochim Biophys Acta 1693 (2004) 37-45
68. Kang S.W., Chang T.S., Lee T.H., Kim E.S., Yu D.Y., and Rhee S.G. Cytosolic peroxiredoxin attenuates the activation of Jnk and p38 but potentiates that of Erk in Hela cells stimulated with tumor necrosis factor-alpha. J Biol Chem 279 (2004) 2535-2543
69. Chae H.Z., Robison K., Poole L.B., Church G., Storz G., and Rhee S.G. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci USA 91 (1994) 7017-7021
70. Rhee S.G., Kang S.W., Chang T.S., Jeong W., and Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52 (2001) 35-41
71. Hofmann B., Hecht H.J., and Flohe L. Peroxiredoxins. Biol Chem 383 (2002) 347-364
72. Tobiume K., Matsuzawa A., Takahashi T., Nishitoh H., Morita K., Takeda K., et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2 (2001) 222-228